📌 Key Takeaways
- Topic: Silica Supply Chain: Raw Materials, Production Hubs and Risks
- Keywords: silica manufacturer China
- Published: 2026-11-20 05:19:01
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
With the rapid expansion of nanotechnology, nanomaterials have demonstrated great promise in the biomedical field due to their outstanding physicochemical properties. A variety of nanoformulations have been widely explored and developed for cargo delivery, 1, 2, 3, 4, 5 sickness diagnosis, 6, 7, 8, 9 and therapeutic purposes. 10, 11, 12, 13 Compared to macroscale counterparts, nanoformulations always enjoy the distinctive merits, including higher bioavailability, cut down toxic effects and boosted selectivity, in the living organism. 14 Typically, nanoformulations contain two major categories: organic and inorganic nanoformulations. 14, 15 Organic ones such as liposomes and polymers have been demonstrated to be a really effective and secure class of drug carriers, as evidenced by the fact that Doxil l is the first American Food and Drug Administration (FDA)-approved nanoliposomal drug formulation, 16 and the recently reported development of two lipid nanoparticles (NPs)-based COVID-19 mRNA vaccines (BNT162b2 and mRNA-1273). 17 For inorganic NPs-based formulations, though they are slightly inferior to organic NPs-based formulations in terms of biocompatibility and safety, they are superior to organic NPs-based formulations in terms of stability and drug delivery efficiency. Importantly, some distinctive properties possessed by inorganic NPs such as optical, ultrasonic, magnetic and catalytic properties have given rise to some novel NPs-based therapies, i.e., photothermal therapy (PTT), 18, 19 photodynamic therapy (PDT), 20, 21 sonodynamic therapy (SDT), 22, 23 chemodynamic therapy (CDT) 24, 25 and nanozyme-based catalytic therapy. 26, 27 Encouragingly, inorganic NPs are also steadily moving to the clinical stage, with about 25 inorganic nanomedicines approved for clinical use. 28
Silica for Tires: How It Reduces Rolling Resistance and Improves Wet Grip
- Fused Silica CAS 60676-86-0: Identification, Properties and Safety Data
- Silica for HPLC: Particle Types, Pore Sizes and Column Performance
- The unique properties of MSNs make it greatly superior for the construction of multifunctional nanocomposites and drug delivery system. Different therapeutic nanoplatforms obtained through the careful design of MSNs have revealed promising potential in the field of targeted disease therapy. Current applications of MSNs include tumor therapy, 367, 368, 369 anti-infection therapy (bacteria and virus), 370, 371, 372, 373 anti-oxidant/anti-inflammatory therapy (Alzheimer's disease, acute kidney injury, etc.), 374, 375, 376 and metabolic diseases treatment (diabetes, osteoporosis, fatty liver, etc) 377, 378, 379, 380 (Fig. 7 ). In general, the targeted therapeutic characteristics of MSNs can be reflected in the following aspects: (1) Loading chemotherapy drugs or other drugs with toxic side influences, so that they can be released in a controlled manner by MSNs at the targeted sites to prevent their premature release. (2) Selective enrichment at the lesion sites through passive targeting or active targeting, resulting in the higher therapeutic efficacy. (3) Use the MSNs matrix to develop a non-invasive, spatial and temporal controllable targeted therapeutic plan, consequently to overcome the limitations and defects of conventional clinical treatment modalities. To date, the emerging targeted therapeutic modalities developed based on MSNs include dynamic therapy such as photodynamic, sonodynamic and chemodynamic therapies, thermal ablation therapy such as photothermal therapy and magnetic thermotherapy, enzyme-like catalytic therapy, immunotherapy, gene therapy, and others. Meanwhile, the integration of various therapeutic modalities on a single MSNs is expected to enhance the therapeutic efficacy synergistically (Fig. 7 ). In this part, we will discuss MSNs-based therapeutic modalities.
- What Is Fused Silica Sand? Properties and Uses in Investment Casting and Refractories
- Xu, B., Huang, Z., Liu, Y., Li, S. & Liu, H. MOF-based nanomedicines encouraged by structures of natural active factors. Nano Today 48, 101690 (2023). Article CAS Google Scholar
- High Purity Quartz Sand: Specifications, Uses in Solar and Semiconductors, and Suppliers
- Huo, M., Wang, L., Chen, Y. & Shi, J. Tumor-selective catalytic nanomedicine by nanocatalyst delivery. Nat. Commun. 8, 357 (2017). Article PubMed Central PubMed Google Scholar
Dental Grade Silica: Uses in Dental Composites, Toothpaste and Oral Care
What is silica (SiO₂)?
HD silica
What is the difference between fumed silica and precipitated silica?
silane coupling agent
What drives silica raw material prices?
silica anti caking agent
Cite this article: Silica Raw Materials News. "Talc Powder vs Silica: Differences and Which Filler to Choose
." Published 2026-11-20 05:19:01.
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.